Huapont Life Sciences Co.,Ltd. (SHE:002004)

Huapont Life Sciences Revenue

Huapont Life Sciences had revenue of 2.81B CNY in the quarter ending September 30, 2026, a decrease of -10.65%. This brings the company's total for the last twelve months to 11.14B, down -5.90% year-over-year. In the year 2025, Huapont Life Sciences had annual revenue of 11.51B, down -1.31%. That makes Huapont Life Sciences the 5,592nd largest company in the world by revenue and 737th in China.

• Revenue (ttm): 11.14B
• Revenue Growth: -5.90%
• P/S Ratio: 0.83
• Revenue / Employee: 932.45K
• Employees: 11,950
• Market Cap: 9.23B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Agrochemical New Materials Division 6.50B 55.5%
• Pharmaceutical Division 3.30B 28.2%
• Tourism Department 1.23B 10.5%
• Medicine Business 417.67M 3.6%
• Other Business Units 184.70M 1.6%
• Headquarters of The Group 83.18M 0.7%

By Geography

Chart

• China 8.00B 69.5%
• Overseas 3.51B 30.5%

Fiscal year ended Dec 31, 2025 See the full Huapont Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	11.51B	-152.32M	-1.31%
Dec 31, 2024	11.66B	70.08M	0.60%
Dec 31, 2023	11.59B	-1.64B	-12.38%
Jan 1, 2023	13.23B	801.24M	6.45%
Jan 1, 2022	12.43B	1.55B	14.29%

Data Source: S&P Global Market Intelligence Last updated: Oct 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error